GNVC on NASDAQ

GenVec

American pharmaceutical company based in Gaithersburg, incorporated in Delaware. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with another stock.

TickerGNVC on NASDAQ¹
Industrypharmaceutical industry¹
HeadquartersGaithersburg¹
Websitewww.genvec.com
Incorporated inDE³
Business address910 Clopper Road, Suite 220N, Gaithersburg, Md 20878³
Filer categorySmaller reporting company³

See how the biggest companies compare on our leaderboards

Leadership

Who has led GenVec, and when. Pick a name to see everywhere that person has worked.

Chief executive

President

Chief financial officer

Douglas J. Swirsky2006–2013

2010201520202025

Chief executive officerDouglas J. Swirsky Sep 5, 2013 to Jun 20, 2017⁴
Chief executive officerCynthia Collins May 25, 2012 to Jan 24, 2013⁵
PresidentDouglas J. Swirsky Sep 5, 2013 to Jun 20, 2017⁴
PresidentCynthia Collins May 25, 2012 to Jan 24, 2013⁵
Chief financial officerDouglas J. Swirsky Sep 19, 2006 to Jan 24, 2013⁶

Board members and other officers (23)

Sr. Director, Corp ControllerJames Vincent Lambert Dec 9, 2014 to Jun 20, 2017⁷
VP, ResearchDouglas E. Brough Jun 28, 2011 to Jun 20, 2017⁸
VP, Legal Affairs and StrategyMichael C. Tucker Jun 28, 2011 to Jan 20, 2012⁹
Chief Medical OfficerThomas Andrew Davis Jan 5, 2006 to Jan 26, 2006¹⁰
Senior Vice PresidentBryan T. Butman Apr 13, 2006 to Jun 20, 2017¹¹
Vice PresidentNita U. Patel Apr 13, 2006 to Jan 22, 2007¹²
Vice PresidentRussell P. Wesdyk Apr 13, 2006 to Apr 13, 2006¹³
Senior VP, Product DevelopmentMark Owens Thornton Dec 27, 2006 to Jan 22, 2010¹⁴
Board memberMichael Richman Apr 22, 2015 to Jun 20, 2017¹⁵
Board memberQuinterol J. Mallette Nov 6, 2014 to Jun 20, 2017¹⁶
Board memberDouglas J. Swirsky Sep 5, 2013 to Jun 20, 2017⁴
Board memberStefan Loren Sep 24, 2013 to Jun 20, 2017¹⁷
Board memberCynthia Collins May 25, 2012 to Jan 24, 2013⁵
Board memberEdward M. Connor Jun 16, 2011 to Jul 13, 2012¹⁸
Board memberKevin M. Rooney Jan 18, 2008 to Jul 13, 2012¹⁹
Board memberMarc R. Schneebaum Apr 20, 2007 to Jun 20, 2017²⁰
Board memberFranklin Barbara Hackman Jun 26, 2006 to Jun 26, 2006²¹
Board memberHarold R. Werner Jun 26, 2006 to Jun 15, 2007²²
Board memberJoshua Ruch Jun 26, 2006 to Jun 18, 2010²³
Board memberStelios Papadopoulos Jun 26, 2006 to Jun 26, 2006²⁴
Board memberWayne T. Hockmeyer Jun 26, 2006 to Jun 20, 2017²⁵
Board memberWillam N. Kelley Jun 26, 2006 to Jun 20, 2017²⁶
Board memberZola P. Horovitz Jun 26, 2006 to Sep 5, 2013²⁷

Timeline

Sep 5, 2013New chief executive Douglas J. Swirsky becomes CEO⁴
May 25, 2012New chief executive Cynthia Collins becomes CEO⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataGenVec on Wikidata
2
SEC EDGARGenVec filings on SEC EDGAR
3
SEC EDGARGenVec filings on SEC EDGAR
4
SEC EDGARDouglas J. Swirsky, Chief executive officer
5
SEC EDGARCynthia Collins, Chief executive officer
6
SEC EDGARDouglas J. Swirsky, Chief financial officer
7
SEC EDGARJames Vincent Lambert, Sr. Director, Corp Controller
8
SEC EDGARDouglas E. Brough, VP, Research
9
SEC EDGARMichael C. Tucker, VP, Legal Affairs and Strategy
10
SEC EDGARThomas Andrew Davis, Chief Medical Officer
11
SEC EDGARBryan T. Butman, Senior Vice President
12
SEC EDGARNita U. Patel, Vice President
13
SEC EDGARRussell P. Wesdyk, Vice President
14
SEC EDGARMark Owens Thornton, Senior VP, Product Development
15
SEC EDGARMichael Richman, Board member
16
SEC EDGARQuinterol J. Mallette, Board member
17
SEC EDGARStefan Loren, Board member
18
SEC EDGAREdward M. Connor, Board member
19
SEC EDGARKevin M. Rooney, Board member
20
SEC EDGARMarc R. Schneebaum, Board member
21
SEC EDGARFranklin Barbara Hackman, Board member
22
SEC EDGARHarold R. Werner, Board member
23
SEC EDGARJoshua Ruch, Board member
24
SEC EDGARStelios Papadopoulos, Board member
25
SEC EDGARWayne T. Hockmeyer, Board member
26
SEC EDGARWillam N. Kelley, Board member
27
SEC EDGARZola P. Horovitz, Board member